发明名称 Nucleic acids encoding human glucagon receptor antibodies
摘要 The present invention provides antibodies that bind to the human glucagon receptor, designated GCGR and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human GCGR. The antibodies of the invention are useful for lowering blood glucose levels and blood ketone levels and are also useful for the treatment of diseases and disorders associated with one or more GCGR biological activities, including the treatment of diabetes, diabetic ketoacidosis and long-term complications associated with diabetes, or other metabolic disorders characterized in part by elevated blood glucose levels.
申请公布号 US9127068(B2) 申请公布日期 2015.09.08
申请号 US201314014517 申请日期 2013.08.30
申请人 Regeneron Pharmaceuticals, Inc. 发明人 Okamoto Haruka;Sleeman Mark;Harp Joyce
分类号 C12N15/00;C12P21/06;C12N1/20;C12N5/00;C12N5/02;C12N15/74;C07H21/04;C07K16/28;A61K39/395;A61K39/00 主分类号 C12N15/00
代理机构 Brownstein Hyatt Farber Schreck, LLP 代理人 Brownstein Hyatt Farber Schreck, LLP ;Crowley-Weber Cara L.;Mallon Veronica
主权项 1. A vector comprising an isolated nucleic acid molecule encoding a recombinant human antibody or antigen-binding fragment thereof that specifically binds human glucagon receptor (hGCGR), wherein the antibody or antigen-binding fragment thereof comprises the three heavy chain CDRs (HCDR1, HCDR2 and HCDR3) contained within the heavy chain variable region (HCVR) amino acid sequence of SEQ ID NO 86; and the three light chain CDRs (LCDR1, LCDR2 and LCDR3) contained within the light chain variable region (LCVR) amino acid sequence of SEQ ID NO: 88.
地址 Tarrytown NY US